Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

284
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
284
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

324
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
324
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

337
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
337

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Severe Pulmonary Coccidioidomycosis Treated With Systemic Corticosteroids in an Adolescent Child.

Case reports in pediatrics·2026
Same author

Adeno-Associated Virus Type 2 and Human Adenovirus Species F Type 41 Co-infection Associated with Acute Severe Hepatitis in Children, California, USA.

Emerging infectious diseases·2026
Same author

Response to Comment on 'Evaluating potential associations between prior maternal yellow fever vaccination and protection against infant adverse outcomes following Zika virus antenatal exposure'.

International journal of epidemiology·2026
Same author

Maternal-infant immune signatures in infants at risk for SARS-CoV-2-associated neurodevelopmental disorders.

Communications biology·2026
Same author

Rising burden of severe pediatric coccidioidomycosis: a 25-year single-center study.

Journal of the Pediatric Infectious Diseases Society·2026
Same author

Cardiac findings in infants with in utero exposure to Zika virus - a follow up longitudinal study.

PLoS neglected tropical diseases·2026

Related Experiment Video

Updated: Feb 18, 2026

Establishing Mouse Models for Zika Virus-induced Neurological Disorders Using Intracerebral Injection Strategies: Embryonic, Neonatal, and Adult
09:39

Establishing Mouse Models for Zika Virus-induced Neurological Disorders Using Intracerebral Injection Strategies: Embryonic, Neonatal, and Adult

Published on: April 26, 2018

9.2K

Zika clinical updates: implications for pediatrics.

Kristina Adachi1, Karin Nielsen-Saines

  • 1Department of Pediatrics, Division of Infectious Diseases, David Geffen School of Medicine at UCLA, Los Angeles, California, USA.

Current Opinion in Pediatrics
|November 28, 2017
PubMed
Summary

Pediatricians must stay updated on Zika virus (ZIKV) epidemiology, clinical presentation, and management to effectively care for infants and children. Comprehensive knowledge is crucial, especially with evolving screening guidelines for pregnant women.

More Related Videos

Zika Virus Infectious Cell Culture System and the In Vitro Prophylactic Effect of Interferons
09:11

Zika Virus Infectious Cell Culture System and the In Vitro Prophylactic Effect of Interferons

Published on: August 23, 2016

21.4K
Modelling Zika Virus Infection of the Developing Human Brain In Vitro Using Stem Cell Derived Cerebral Organoids
09:18

Modelling Zika Virus Infection of the Developing Human Brain In Vitro Using Stem Cell Derived Cerebral Organoids

Published on: September 19, 2017

11.0K

Related Experiment Videos

Last Updated: Feb 18, 2026

Establishing Mouse Models for Zika Virus-induced Neurological Disorders Using Intracerebral Injection Strategies: Embryonic, Neonatal, and Adult
09:39

Establishing Mouse Models for Zika Virus-induced Neurological Disorders Using Intracerebral Injection Strategies: Embryonic, Neonatal, and Adult

Published on: April 26, 2018

9.2K
Zika Virus Infectious Cell Culture System and the In Vitro Prophylactic Effect of Interferons
09:11

Zika Virus Infectious Cell Culture System and the In Vitro Prophylactic Effect of Interferons

Published on: August 23, 2016

21.4K
Modelling Zika Virus Infection of the Developing Human Brain In Vitro Using Stem Cell Derived Cerebral Organoids
09:18

Modelling Zika Virus Infection of the Developing Human Brain In Vitro Using Stem Cell Derived Cerebral Organoids

Published on: September 19, 2017

11.0K

Area of Science:

  • Pediatric Infectious Diseases
  • Virology
  • Public Health

Background:

  • Zika virus (ZIKV), a mosquito-borne flavivirus, is a significant cause of congenital infections.
  • Understanding ZIKV's impact on pediatric populations is critical for healthcare providers.

Purpose of the Study:

  • To summarize the current epidemiology of ZIKV.
  • To outline the clinical presentation and complications of ZIKV infection in children.
  • To review ZIKV diagnosis, management, treatment, and prevention strategies.

Main Methods:

  • Literature review of recent ZIKV research.
  • Synthesis of clinical findings and epidemiological data.
  • Analysis of current diagnostic and management guidelines.

Main Results:

  • ZIKV poses a significant threat as a cause of congenital infection.
  • Clinical manifestations in children range from acute illness to severe congenital complications.
  • Evolving understanding necessitates updated clinical knowledge for pediatricians.

Conclusions:

  • Pediatricians require up-to-date knowledge on ZIKV for optimal patient care.
  • Changes in screening guidelines emphasize the need for comprehensive clinical understanding.
  • Effective management and prevention rely on continuous learning in ZIKV research.